Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Canadian start-up Cytophage believes it can revolutionize the way bacterial infections are treated with its bacteriophage technology.
Norwegian aquaculture firm Pharmaq has established a strategic partnership aimed at improving productivity and sustainability in the tilapia value chain in Colombia.
A new study by The Roslin Institute aims to identify genes that are vital in reducing infection of influenza A virus in pigs and chickens.
Research from Veramaris has revealed a strong connection between omega-3 eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) content in salmon, and increased salmon consumption frequency among US consumers.
Merck Animal Health has launched its Innovax ND-ILT vaccine for poultry in the US.
Swiss firm Embion Technologies is looking to source series B funding of $3 million to develop its prebiotics.
The number of pigs slaughtered in Japan has stayed steady despite outbreaks of porcine epidemic diarrhea virus (PEDV) on farms.
US biotechnology firm Mazen Animal Health is ready to scale up its R&D for low-cost oral recombinant vaccines.
Despite its name, White Dog Labs is not focused on the canine therapeutics space. In fact, because it deals with the fermentation process, the company took the 'White Dog' moniker from a slang term for moonshine – the illicit distillery of whisky or bourbon. Animal Pharm editor Joseph Harvey spoke to the New Castle, Delaware-based company about how it is producing a suite of nutritional products for food animals.
Delaware-headquartered DuPont Animal Nutrition has launched Syncra AVI in the Asia Pacific region.
Austrian animal nutrition company Biomin has launched FUMzyme sol, which it claims is the first water-soluble purified enzyme that degrades fumonisins into non-toxic metabolites.
AgResults is going to follow up the success of its ongoing brucellosis vaccine development competition with a project focused on developing a vaccine for foot-and-mouth disease (FMD).
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.